Metocin 4-HO-MET 21 mg Pellets – Research Material

Metocin (4-HO-MET), also known as 4-hydroxy-N-methyl-N-ethyltryptamine, is a synthetic tryptamine-related research compound that has been discussed in chemical and analytical research.

The compound has attracted scientific interest because of its molecular structure and relationship to other substituted tryptamines. However, available information concerning its pharmacology, toxicology, metabolism, and long-term biological effects remains limited.

This material is presented strictly for permitted laboratory, analytical, and scientific research and is not intended for human or veterinary consumption.

Compound Information

What Is 4-HO-MET?

4-HO-MET is a substituted tryptamine research compound that has been investigated in the context of analytical chemistry and comparative research involving structurally related tryptamines.

Its chemical structure provides opportunities for research into compound identification, analytical characterization, structure-property relationships, metabolism, and related areas of scientific investigation.

Researchers should not assume biological activity, potency, toxicity, or safety characteristics based solely on similarities between 4-HO-MET and other tryptamine compounds.

Research Applications

Subject to applicable legislation and institutional approval, 4-HO-MET may be relevant to:

• Analytical chemistry
• Chemical identification
• Tryptamine compound characterization
• Structure-property research
• Analytical method development
• Metabolic research
• Reference-material studies
• Comparative analysis of substituted tryptamines
• Scientific characterization

Qualified laboratories should independently establish the identity and characteristics of the supplied material using appropriate analytical methods.

4-HO-MET 21 mg Pellets

The product is supplied in pellet form with a declared 21 mg quantity of 4-HO-MET per pellet.

The stated amount should be treated as a product specification rather than a human-use dose. Researchers should use batch-specific documentation and validated analytical procedures when determining the actual composition of supplied material.

Any inactive ingredients or excipients should be confirmed through the applicable product specification or batch documentation rather than assumed from generic pellet formulations.

Analytical & Scientific Research

Research involving Metocin 4-HO-MET may include investigations into:

• Chemical identity
• Sample composition
• Analytical detection
• Chromatographic characteristics
• Mass-spectral characteristics
• Stability and storage characteristics
• Metabolic or transformation products
• Structural relationships among substituted tryptamines
• Development or validation of analytical methods

Research findings should be evaluated using validated laboratory procedures and appropriate reference materials.

Product Quality & Documentation

Where available, product information should be supported by batch-specific documentation such as a Certificate of Analysis (CoA).

Relevant documentation may include:

• Compound identity
• Batch or lot number
• Analytical testing
• Assay or purity results
• Stated composition
• Storage requirements
• Safety information

Specific purity or quality claims should only be made where supported by appropriate documentation for the relevant batch.

Safety & Handling

4-HO-MET should be handled only by appropriately trained laboratory personnel under a suitable laboratory risk assessment.

Researchers should:

• Review the applicable Safety Data Sheet (SDS) before handling.
• Use appropriate laboratory PPE.
• Minimize unnecessary exposure.
• Maintain suitable ventilation and containment.
• Keep the material properly labelled.
• Store according to documented conditions.
• Follow established procedures for spills or accidental exposure.
• Dispose of unused material according to applicable regulations.

Because toxicological information may be limited, researchers should apply appropriate precautionary controls rather than assuming an established safety profile.

Regulatory Compliance

For permitted laboratory, analytical, and scientific research only. Not for human or veterinary consumption.

The legal status of 4-HO-MET may vary between jurisdictions and can change over time.

Before acquiring, importing, possessing, transporting, storing, or researching this material, customers and research institutions should verify:

• Applicable national legislation
• Controlled-substance requirements where applicable
• Import and export restrictions
• Institutional policies
• Laboratory safety requirements
• Required licenses or authorizations

No Human-Use Instructions

This page does not provide human-use dosage information, administration instructions, titration guidance, recreational-use information, or recommendations for consumption.

The 21 mg specification identifies the declared quantity contained in each research pellet; it is not presented as a recommended human dose.

4-HO-MET is not presented as a medicine, therapeutic product, dietary supplement, or consumer-use substance.

Product Documentation

Where available, researchers should review documentation associated with the specific batch, including:

• Certificate of Analysis (CoA)
• Safety Data Sheet (SDS)
• Batch/lot information
• Product specifications
• Ingredient or excipient information where applicable
• Applicable regulatory documentation

These documents can assist qualified researchers in evaluating the identity, composition, stated characteristics, storage requirements, and handling considerations of the supplied research material.

Research Material Information

Metocin 4-HO-MET 21 mg Pellets may be relevant to permitted laboratory investigations involving substituted tryptamine chemistry, analytical characterization, and scientific research.

ChemsonlineEU — Research Materials for Scientific Investigation